Details for New Drug Application (NDA): 211180
✉ Email this page to a colleague
The generic ingredient in HALOPERIDOL DECANOATE is haloperidol decanoate. There are twenty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Summary for 211180
Tradename: | HALOPERIDOL DECANOATE |
Applicant: | Zydus Pharms |
Ingredient: | haloperidol decanoate |
Patents: | 0 |
Suppliers and Packaging for NDA: 211180
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HALOPERIDOL DECANOATE | haloperidol decanoate | INJECTABLE;INJECTION | 211180 | ANDA | Zydus Pharmaceuticals USA Inc. | 70710-1461 | 70710-1461-6 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70710-1461-6) / 1 mL in 1 VIAL, SINGLE-DOSE |
HALOPERIDOL DECANOATE | haloperidol decanoate | INJECTABLE;INJECTION | 211180 | ANDA | Zydus Pharmaceuticals USA Inc. | 70710-1461 | 70710-1461-9 | 3 VIAL, SINGLE-DOSE in 1 CARTON (70710-1461-9) / 1 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50MG BASE/ML | ||||
Approval Date: | Oct 22, 2019 | TE: | AO | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/ML | ||||
Approval Date: | Oct 22, 2019 | TE: | AO | RLD: | No |
Complete Access Available with Subscription